Canopy Growth (TSE:WEED – Free Report) had its target price decreased by ATB Capital from C$4.00 to C$3.20 in a report released on Monday morning,BayStreet.CA reports. ATB Capital currently has an underperform rating on the stock.
Separately, Canaccord Genuity Group dropped their price objective on shares of Canopy Growth from C$2.50 to C$1.50 and set a “sell” rating for the company in a research note on Monday. Four investment analysts have rated the stock with a sell rating and one has issued a hold rating to the company’s stock. According to MarketBeat.com, Canopy Growth has an average rating of “Reduce” and an average price target of C$5.40.
View Our Latest Analysis on WEED
Canopy Growth Stock Performance
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Stories
- Five stocks we like better than Canopy Growth
- Learn Technical Analysis Skills to Master the Stock Market
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Effectively Use the MarketBeat Ratings Screener
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Short a Stock in 5 Easy Steps
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.